Randomization and treatment
toxicity, PD
DISEASE
A total of 100 patients, 50 in each arm, will be included (Fig. Summary of eligibility criteria and randomizationPatients may continue treatment until progressive disease (PD), unacceptable toxicity, withdrawal of consent, or until the treating physician judges that continued treatment poses an unacceptable risk to the patient’s health. In case of treatment discontinuation, patients are allowed further treatment according to Danish guidelines [